Related Experiment Videos
The value of prostate-specific antigen in the management of localized prostatic cancer
P C Walsh1, J E Oesterling, J I Epstein
1Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Progress in Clinical and Biological Research
|January 1, 1989
Abstract:
Prostate-specific antigen has proven to be a new useful marker for the evaluation of men with prostatic cancer. In addition to its proven value for immunohistochemical staining and for the followup evaluation of men treated with hormonal therapy, the monoclonal immunoradiometric assay for PSA has proven to be a unique, sensitive, and specific marker for the followup evaluation of men who have undergone radical prostatectomy.